Terms: = Thyroid cancer AND NCOA1, RIP160, 8648, ENSG00000084676, NCoA-1, SRC1, MGC129719, MGC129720, F-SRC-1
24 results:
1. Association between thyroid cancer and Weight Change: A Longitudinal Follow-Up Study.
Jin YJ; Hah JH; Kwon MJ; Kim JH; Kim JH; Kim SK; Park B; Choi HG
Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682332
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathologic Characterization of GREB1-rearranged Uterine Sarcomas With Variable Sex-Cord Differentiation.
Lee CH; Kao YC; Lee WR; Hsiao YW; Lu TP; Chu CY; Lin YJ; Huang HY; Hsieh TH; Liu YR; Liang CW; Chen TW; Yip S; Lum A; Kuo KT; Jeng YM; Yu SC; Chung YC; Lee JC
Am J Surg Pathol; 2019 Jul; 43(7):928-942. PubMed ID: 31094921
[TBL] [Abstract] [Full Text] [Related]
3. Steroid receptor coactivator-1 interacts with NF-κB to increase VEGFC levels in human thyroid cancer.
Gao B; Guo L; Luo D; Jiang Y; Zhao J; Mao C; Xu Y
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29717026
[TBL] [Abstract] [Full Text] [Related]
4. The co-regulators SRC-1 and SMRT are involved in interleukin-6-induced androgen receptor activation.
Wang Q; Wang H; Ju Q; Ding Z; Ge X; Shi QM; Zhou JL; Zhou XL; Zhang JP; Zhang MR; Yu HM; Xu LC
Eur Cytokine Netw; 2016 Nov; 27(4):108-113. PubMed ID: 28396297
[TBL] [Abstract] [Full Text] [Related]
5. Somatic mutation profiling of follicular thyroid cancer by next generation sequencing.
Swierniak M; Pfeifer A; Stokowy T; Rusinek D; Chekan M; Lange D; Krajewska J; Oczko-Wojciechowska M; Czarniecka A; Jarzab M; Jarzab B; Wojtas B
Mol Cell Endocrinol; 2016 Sep; 433():130-7. PubMed ID: 27283500
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition effect of cypermethrin mediated by co-regulators SRC-1 and SMRT in interleukin-6-induced androgen receptor activation.
Wang Q; Zhou JL; Wang H; Ju Q; Ding Z; Zhou XL; Ge X; Shi QM; Pan C; Zhang JP; Zhang MR; Yu HM; Xu LC
Chemosphere; 2016 Sep; 158():24-9. PubMed ID: 27239967
[TBL] [Abstract] [Full Text] [Related]
7. ncoa1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription.
Qin L; Xu Y; Xu Y; Ma G; Liao L; Wu Y; Li Y; Wang X; Wang X; Jiang J; Wang J; Xu J
Oncotarget; 2015 Sep; 6(27):23890-904. PubMed ID: 26287601
[TBL] [Abstract] [Full Text] [Related]
8. A new strategy for selective targeting of progesterone receptor with passive antagonists.
Khan JA; Tikad A; Fay M; Hamze A; Fagart J; Chabbert-Buffet N; Meduri G; Amazit L; Brion JD; Alami M; Lombès M; Loosfelt H; Rafestin-Oblin ME
Mol Endocrinol; 2013 Jun; 27(6):909-24. PubMed ID: 23579486
[TBL] [Abstract] [Full Text] [Related]
9. The role of oestrogen receptor {alpha} in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2.
Kavanagh DO; McIlroy M; Myers E; Bane F; Crotty TB; McDermott E; Hill AD; Young LS
Endocr Relat Cancer; 2010 Mar; 17(1):255-64. PubMed ID: 20032008
[TBL] [Abstract] [Full Text] [Related]
10. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract] [Full Text] [Related]
11. Altered VDR-mediated transcriptional activity in prostate cancer stroma.
Hidalgo AA; Paredes R; Garcia VM; Flynn G; Johnson CS; Trump DL; Onate SA
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):731-6. PubMed ID: 17368189
[TBL] [Abstract] [Full Text] [Related]
12. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
Cano P; Godoy A; Escamilla R; Dhir R; Onate SA
Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758
[TBL] [Abstract] [Full Text] [Related]
13. Clinical and molecular features of a TSH-secreting pituitary microadenoma.
Usui T; Izawa S; Sano T; Tagami T; Nagata D; Shimatsu A; Takahashi JA; Naruse M
Pituitary; 2005; 8(2):127-34. PubMed ID: 16379036
[TBL] [Abstract] [Full Text] [Related]
14. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract] [Full Text] [Related]
15. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract] [Full Text] [Related]
16. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression.
Uchikawa J; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Oka K; Konishi I
Cancer; 2003 Nov; 98(10):2207-13. PubMed ID: 14601091
[TBL] [Abstract] [Full Text] [Related]
17. Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors.
Ko L; Cardona GR; Henrion-Caude A; Chin WW
Mol Cell Biol; 2002 Jan; 22(1):357-69. PubMed ID: 11739747
[TBL] [Abstract] [Full Text] [Related]
18. Temporal/spatial expression of nuclear receptor coactivators in the mouse lung.
Naltner A; Wert S; Whitsett JA; Yan C
Am J Physiol Lung Cell Mol Physiol; 2000 Dec; 279(6):L1066-74. PubMed ID: 11076796
[TBL] [Abstract] [Full Text] [Related]
19. Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity.
Martini PG; Delage-Mourroux R; Kraichely DM; Katzenellenbogen BS
Mol Cell Biol; 2000 Sep; 20(17):6224-32. PubMed ID: 10938099
[TBL] [Abstract] [Full Text] [Related]
20. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
[TBL] [Abstract] [Full Text] [Related]
[Next]
